Clinical Trials Directory

Trials / Unknown

UnknownNCT01112436

The Effect of Periarticular Multi-Drug Regimen on Pain After Partial Hip Replacement

The Effect of Periarticular Injection of Multi-drug Regimen on Pain in Patient Receiving Partial Hip Replacement:Randomized Prospective Study.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
258 (estimated)
Sponsor
Chung-Ang University Hosptial, Chung-Ang University College of Medicine · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This prospective randomized study aims to evaluate the effectiveness of periarticular multi-drug regimen injection on the relief of pain in patients undergoing partial hip replacement. Total 258 patients will be randomized into one of two groups (groupC or groupI) based on Excel number generation. Patients in group C will receive no medication intraoperatively, and patients in group I will receive oral oxycodone and celecoxib preoperatively and a periarticular injection of multi-drug regimen during operation. Visual analogue scale pain scores, fentanyl consumption and the frequency at which patients pushed the button (FPB) of a patient-controlled analgesia system will be recorded at 1, 4, 7 postoperative day.

Detailed description

Patients in group I will receive oxycodone SR 10 mg, and celecoxib 200 mg with 10 ml of water 1 hour before surgery. And patients in group I will receive periarticular injection of 50 ml solution which contains ropivacaine 15 mg, epinephrine 0.3 mg, cefmetazole 1000mg, ketorolac 30 mg and morphine HCL 10mg before closure of surgical wound. Patients in group C will receive no medication.

Conditions

Interventions

TypeNameDescription
DRUGperiarticular injection of multidrug regimenperiarticular injection of combination of ropivacaine 15 mg, epinephrine 0.3mg, cefmetazole 1000mg, ketorolac 30mg, morphine HCL 10 mg
DRUGnone of medication preoperatively and intraoperativelyPatients in Group C wil receive none of medication preoperatively and intraoperatively

Timeline

Start date
2010-05-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2010-04-28
Last updated
2011-06-27

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01112436. Inclusion in this directory is not an endorsement.